Delivery Order SPE2DB22D3004-SPE2DB24FRS51
Award Date
9/3/24
Potential Completion Date
9/4/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FQQ61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,790.07 firm-fixed-price delivery order is for the supply of 4568201901 - XTAMPZA ER 36 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of May 12, 2025 and was awarded on May 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.62, is a Delivery Order for the supply of XTAMPZA ER 27 MG CAPSULE 100S. The contract has an ultimate completion date of February 28, 2025 and is a Firm Fixed Price arrangement. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.84 firm-fixed-price delivery order is for the supply of XTAMPZA ER 9 MG CAPSULE 100S, a specialty pharmaceutical product. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a $1,268.31 firm fixed price delivery order for the supply of XTAMPZA ER 36 MG capsules. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the delivery of XTAMPZA ER 36 MG capsules in 100-count bottles. The award, valued at $1,268.31, is a firm fixed price delivery order with an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. Additionally,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,439.20, is for the delivery of XTAMPZA ER 18 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 22, 2025. This award is not associated with a set-aside designation. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,706.55 firm fixed-price delivery order is for the supply of XTAMPZA ER 27 MG capsules in 100-count bottles. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, with ID SPE2DX22D0010|SPE2D825FDF86, was granted by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,711.42 Firm Fixed Price Delivery Order contract is for the provision of XTAMPZA ER CAPS 36MG, a pharmaceutical product. The contract has a period of performance through February 5, 2025 and does not include a set-aside designation, indicating open...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $4,384.91 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of the pharmaceutical product XTAMPZA ER 36 MG CAPSULE. This order is being fulfilled under an existing indefinite delivery contract (IDC) issued by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,499.73 firm fixed-price delivery order is for the supply of 4565121144 - XTAMPZA ER 9 MG CAPSULE 100S, a pharmaceutical product. The award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle...